Emergency Medicine Pulmonary Embolism Testing Multicentre Study: Lung Diseases and Conditions - Pulmonary Embolism - Insurance News | InsuranceNewsNet

InsuranceNewsNet — Your Industry. One Source.™

Sign in
  • Subscribe
  • About
  • Advertise
  • Contact
Home Now reading Newswires
Topics
    • Advisor News
    • Annuity Index
    • Annuity News
    • Companies
    • Earnings
    • Fiduciary
    • From the Field: Expert Insights
    • Health/Employee Benefits
    • Insurance & Financial Fraud
    • INN Magazine
    • Insiders Only
    • Life Insurance News
    • Newswires
    • Property and Casualty
    • Regulation News
    • Sponsored Articles
    • Washington Wire
    • Videos
    • ———
    • About
    • Meet our Editorial Staff
    • Advertise
    • Contact
    • Newsletters
  • Exclusives
  • NewsWires
  • Magazine
  • Newsletters
Sign in or register to be an INNsider.
  • AdvisorNews
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Exclusives
  • INN Magazine
  • Insurtech
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Video
  • Washington Wire
  • Life Insurance
  • Annuities
  • Advisor
  • Health/Benefits
  • Property & Casualty
  • Insurtech
  • About
  • Advertise
  • Contact
  • Editorial Staff

Get Social

  • Facebook
  • X
  • LinkedIn
Newswires
Newswires RSS Get our newsletter
Order Prints
April 1, 2024 Newswires
Share
Share
Post
Email

Emergency Medicine Pulmonary Embolism Testing Multicentre Study: Lung Diseases and Conditions – Pulmonary Embolism

NewsRx Hematology Daily

2024 APR 01 (NewsRx) -- By a News Reporter-Staff News Editor at NewsRx Hematology Daily -- Staff editors report on the newly launched clinical trial, NCT06320236, which has the following summary description: “It is important to diagnose pulmonary embolism in a timely manner to prevent death and long-term disability. More than half a million people (4-5% of emergency department patients) are tested for pulmonary embolism, although positive results are low. Imaging for PE testing exposes patients to radiation, is expensive, adds time to the emergency visit, and can lead to a false positive diagnoses. Existing protocols aimed at reducing unnecessary pulmonary embolism imaging are complex and seldom used by emergency physicians. Too many patients undergo unnecessary pulmonary embolism imaging. We have created a new tool (called Adjust-Unlikely) which could safely reduce pulmonary embolism imaging in Canada. Our research group composed of researchers, emergency physicians, and patients developed the Adjust-Unlikely clinical decision rule: a rule which has been customized for emergency physicians and emergency patients. Adjust-Unlikely is highly sensitive at the bedside, meaning there are very few false negative results. Our study aim is to prospectively validate Adjust-Unlikely pulmonary embolism testing in emergency patients with suspected pulmonary embolism.”

As a matter of record, on March 21, 2024, NewsRx staff editors report that the available information provided by Queen’s University on this trial include:

Tracking Information

Trial Identifier NCT06320236
First Submitted Date March 13, 2024
First Posted Date March 20, 2024
Results First Submitted Date Not Provided
Results First Posted Date Not Provided
Last Update Submitted Date March 13, 2024
Last Update Posted Date March 20, 2024
Primary Completion Date September 30, 2026
Actual Start Date January 1, 2024
Current Primary Outcome Measures •Venous thrombosis [ Time Frame: 30 days ]
Current Secondary Outcome Measures •Venous thrombosis [ Time Frame: 90 days ]
•Index presentation Adjust-Unlikely testing results [ Time Frame: 90 days ] -- Positive or negative ‘Adjust-Unlikely’ testing result
Other Outcome Measures Not Provided
Change History Complete list of historical revisions of study NCT06320236

Descriptive Information

Brief Title Emergency Medicine Pulmonary Embolism Testing Multicentre Study
Official Title Emergency Medicine Pulmonary Embolism Testing Multicentre Study
Brief Summary It is important to diagnose pulmonary embolism in a timely manner to prevent death and long-term disability. More than half a million people (4-5% of emergency department patients) are tested for pulmonary embolism, although positive results are low. Imaging for PE testing exposes patients to radiation, is expensive, adds time to the emergency visit, and can lead to a false positive diagnoses. Existing protocols aimed at reducing unnecessary pulmonary embolism imaging are complex and seldom used by emergency physicians. Too many patients undergo unnecessary pulmonary embolism imaging. We have created a new tool (called Adjust-Unlikely) which could safely reduce pulmonary embolism imaging in Canada. Our research group composed of researchers, emergency physicians, and patients developed the Adjust-Unlikely clinical decision rule: a rule which has been customized for emergency physicians and emergency patients. Adjust-Unlikely is highly sensitive at the bedside, meaning there are very few false negative results. Our study aim is to prospectively validate Adjust-Unlikely pulmonary embolism testing in emergency patients with suspected pulmonary embolism.
Detailed Description Not Provided
Study Type Observational
Study Phase Not Provided
Study Design Observational Model: Cohort
Time Perspective: Prospective
Condition Pulmonary Embolism
D-dimer
Diagnosis
Intervention •Diagnostic Test: Adjust-Unlikely
Pulmonary embolism will be excluded during emergency department assessment by the combination of: ‘Pulmonary embolism is the most likely diagnosis’ as per the treating physician AND a D-dimer result < 500 ug/L fibrinogen equivalent units; ‘Pulmonary embolism is not the most likely diagnosis’ AND D-dimer < age-adjusted threshold; or, A negative computed tomography scan, planar ventilation perfusion scan or ventilation perfusion-SPECT. Emergency departments will use their local laboratory D-dimer assay.
Study Arms •Emergency department patients tested for pulmonary embolism.
Interventions:
⚬Diagnostic Test: Adjust-Unlikely

Recruitment Information

Recruitment Status Recruiting
Estimated Enrollment 4000
Estimated Completion Date September 30, 2027
Primary Completion Date September 30, 2026 (Final data collection date for primary outcome measure)
Eligibility Inclusion Criteria: Emergency department patient who is tested by an emergency physician for PE Exclusion Criteria: Patient is < 18 years of age No documentation of whether PE is the most likely diagnosis D-dimer is not tested or else not resulted during the emergency visit The D-dimer level is known before documentation of whether PE is the most likely diagnosis The D-dimer is ordered prior to the physician assessing the patient The patient has previously registered that they opt out of all research at the participating site The patient leaves against medical advice The patient has had PE or deep vein thrombosis imaging (CT pulmonary angiogram, ventilation-perfusion scan or lower limb ultrasound) within prior 30 days There is a new (non-PE) indication for anticoagulation The patient was initiated on treatment for presumed PE prior to PE testing The patient has previously been enrolled into the study The patient has a prior history of lower extremity deep vein thrombosis without availability of a baseline ultrasound scan The patient was transferred from another hospital organization The patient does not reside in Ontario The patient has no valid Ontario Health Insurance Plan card
Sex/Gender Sexes Eligible for Study: All
Ages 18 years and older
Accepts Healthy Volunteers No
Contacts Primary contact: Natasha S Clayton, CRA, RA, 4165663590, natasha.clayton@queensu.ca
Listed Location Countries Canada
Removed Location Countries

Administrative Information

NCT Number NCT06320236
Other Study ID Numbers 4603
Has Data Monitoring Committee Not Provided
U.S. FDA-regulated Product Not Provided
Plan to Share Data No
Plan to Share Data (IPD) Description Not Provided
Responsible Party Dr. Kerstin de Wit, Queen’s University
Collaborators Canadian Institutes of Health Research (CIHR)
Investigators Principal Investigator: Kerstin de Wit, MD, Queens University
Information Provided By Queen’s University
Verification Date March 2024

(Our reports deliver fact-based news of research and discoveries from around the world.)

Older

Brown & Brown, Inc. announces senior leadership team appointments

Newer

Examining the Health Effects of iTHRIVE 365 Among Black Same Gender Loving Men: Immune System Diseases and Conditions – HIV/AIDS

Advisor News

  • U.S. debt hits $40 trillion: how to support concerned clients
  • Flourish brings private-bank-like cash solution to MassMutual’s network
  • Majority of Americans concerned recent market highs are unsustainable
  • GLP-1 users choose between medication and retirement saving
  • Gen X and millennials seek new retirement model
More Advisor News

Annuity News

  • Corebridge Financial Introduces Progressive Trigger, a First-of-Its-Kind Index Annuity Strategy Designed to Turn Missed Years into Future Opportunity
  • Insurer proposes $1.1M deal to resolve CA teachers’ annuity fee lawsuit
  • IMOs get frustrated with slow carrier adoption of faster technology
  • New class-action lawsuit targets Delaware Life over annuity disclosures
  • A client remarried: Does their annuity still fit?
More Annuity News

Health/Employee Benefits News

  • UnitedHealth beats Q3 expectations, hikes 2026 guidance
  • What 70% doesn’t tell you
  • Blue Cross faces Michigan lawsuit over alleged monopoly and pricing practices
  • SMH, UnitedHealthcare wrangle over coverage
  • Millions lose private Medicare plans and face rising costs
Sponsor
More Health/Employee Benefits News

Life Insurance News

  • Corebridge Financial Introduces Progressive Trigger, a First-of-Its-Kind Index Annuity Strategy Designed to Turn Missed Years into Future Opportunity
  • BILTIR conference draws more than 750 insurance leaders to Bermuda
  • Death and taxes: How the right analysis for life insurance changes the picture
  • Life insurance applications rise 15.2% in September, MIB reports
  • Flourish brings private-bank-like cash solution to MassMutual’s network
Sponsor
More Life Insurance News

NEWS INSIDE

  • Companies
  • Earnings
  • Economic News
  • INN Magazine
  • Insurtech News
  • Newswires Feed
  • Regulation News
  • Washington Wire
  • Videos

FEATURED OFFERS

Press Releases

  • Lauren Sinnott Named to Ragan’s Top Women in Marketing Awards, Class of 2026 
  • Classic Car Insurer OpenRoad Insurance Expands to 40 U.S. States in Two Years
More Press Releases > Add Your Press Release >

How to Write For InsuranceNewsNet

Find out how you can submit content for publishing on our website.
View Guidelines

Topics

  • Advisor News
  • Annuity Index
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • From the Field: Expert Insights
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Magazine
  • Insiders Only
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Washington Wire
  • Videos
  • ———
  • About
  • Meet our Editorial Staff
  • Advertise
  • Contact
  • Newsletters

Top Sections

  • AdvisorNews
  • Annuity News
  • Health/Employee Benefits News
  • InsuranceNewsNet Magazine
  • Life Insurance News
  • Property and Casualty News
  • Washington Wire

Our Company

  • About
  • Advertise
  • Contact
  • Meet our Editorial Staff
  • Magazine Subscription
  • Write for INN

Sign up for our FREE e-Newsletter!

Get breaking news, exclusive stories, and money- making insights straight into your inbox.

select Newsletter Options
Facebook Linkedin Twitter
© 2026 InsuranceNewsNet.com, Inc. All rights reserved.
  • Terms & Conditions
  • Privacy Policy
  • InsuranceNewsNet Magazine

Sign in with your Insider Pro Account

Not registered? Become an Insider Pro.